S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
How High Can Copper Go? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
How High Can Copper Go? (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
How High Can Copper Go? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
How High Can Copper Go? (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
How High Can Copper Go? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
How High Can Copper Go? (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
How High Can Copper Go? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
How High Can Copper Go? (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
How High Can Copper Go? (Ad)
NASDAQ:BIOSU

BioPlus Acquisition - BIOSU Stock Forecast, Price & News

$9.99
0.00 (0.00%)
(As of 08/10/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.99
$9.99
50-Day Range
$9.97
$10.06
52-Week Range
$9.92
$10.07
Volume
N/A
Average Volume
18,602 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BIOSU stock logo

About BioPlus Acquisition (NASDAQ:BIOSU) Stock

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

BioPlus Acquisition Price Performance

NASDAQ:BIOSU opened at $9.99 on Thursday. The stock has a 50 day moving average of $10.02 and a 200-day moving average of $10.00. BioPlus Acquisition has a 52 week low of $9.92 and a 52 week high of $10.07.

Receive BIOSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOSU Stock News Headlines

See More Headlines
Receive BIOSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
- -
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:BIOSU
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














BIOSU Stock - Frequently Asked Questions

How have BIOSU shares performed in 2022?

BioPlus Acquisition's stock was trading at $10.00 at the start of the year. Since then, BIOSU shares have decreased by 0.1% and is now trading at $9.99.
View the best growth stocks for 2022 here
.

When did BioPlus Acquisition IPO?

(BIOSU) raised $200 million in an IPO on Friday, December 3rd 2021. The company issued 20,000,000 shares at $10.00 per share.

What is BioPlus Acquisition's stock symbol?

BioPlus Acquisition trades on the NASDAQ under the ticker symbol "BIOSU."

Who are BioPlus Acquisition's major shareholders?

BioPlus Acquisition's stock is owned by many different retail and institutional investors. Top institutional investors include Wealthspring Capital LLC (0.00%), Sage Mountain Advisors LLC (0.00%), Wolverine Asset Management LLC (0.00%) and Robinson Capital Management LLC (0.00%).

How do I buy shares of BioPlus Acquisition?

Shares of BIOSU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioPlus Acquisition's stock price today?

One share of BIOSU stock can currently be purchased for approximately $9.99.

How can I contact BioPlus Acquisition?

The official website for the company is bioplusspac.com. The company can be reached via phone at 212 287 4092.

This page (NASDAQ:BIOSU) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.